Back to search

Institutes outside Greece

YAP in mesenchymal stem cells

Abstract

dc:description

Mesenchymal stem cells (MSCs) are the most studied subtype of adult stem cells and have been derived from most postnatal organs and tissues. MSCs are defined as having the capacity to self-renew and to differentiate into both mesodermal and non-mesodermal lineages, and are immunosuppressive. For these properties, MSCs have been considered ideal candidates for regenerative medicine and have been used in several clinical trials. The difficulty, however, to preserve the potency of the cells during culture expansion and to monitor differentiation are obstacles in their use in the clinic and have emphasized the need to investigate molecular pathways underlying stem cell fate-decisions during differentiation in more detail. The Hippo pathway is a recently identified molecular pathway in Drosophila melanogaster and mammals, which controls organ size by regulating cell proliferation, apoptosis and differentiation. The pathway is composed of a core of serine/threonine kinases [Hpo/(MST1/2) and Wts/(LATS1/2)] and scaffold proteins [(Sav/Shrp)/SAV1 and Mats/MOB] that when are activated, phosphorylate and inhibit yes-associated protein (YAP) transcriptional co-activator and tumour suppressor. Inactivation of YAP in some stem and progenitor cells by the Hippo pathway is required for their differentiation. On the contrary, failure to inhibit YAP enhances proliferation and may cause oncogenic transformation.In the present study, the expression of multiple YAP variants was confirmed in human and mouse MSCs. In both human and mouse, YAP was inhibited in response to cell-contact inhibition and remained unchanged during in vitro chondrogenic differentiation. Overexpression of human (hYAP1) variant in C3H/10T1/2 MSC-like cells did not appear to affect colony formation, cell cycle distribution or cell size, but increased cell proliferation, induced cell transformation and reduced the capacity of the cells to differentiate in vitro towards the chondrogenic, adipogenic and osteogenic lineages. The effects of hYAP1 overexpression are hypothesized to be either a result of a nuclear co-factor function or indirectly via protein interactions in the cytoplasmic compartment.YAP and the Hippo pathway are possible pharmacological targets for modulation of MSC function

Degree

thesis:*
Grantor dc:publisher
Institutes outside Greece
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karystinou, Alexandra
  • Καρυστινού, Αλεξάνδρα

Subjects

dc:subject × 21

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/53161

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karystinou, Alexandra; Καρυστινού, Αλεξάνδρα. YAP in mesenchymal stem cells. Institutes outside Greece, 2012. http://hdl.handle.net/10442/hedi/53161